Cargando…

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III

Dengue is the most widespread vector-borne viral disease caused by dengue virus (DENV) for which there are no safe, effective drugs approved for clinical use. Here, by using sequential antigen panning of a yeast antibody library derived from healthy donors against the DENV envelop protein domain III...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Dan, Zhu, Zhongyu, Li, Shun, Deng, Yongqiang, Wu, Yanling, Zhang, Nana, Puri, Vinita, Wang, Chunyu, Zou, Peng, Lei, Cheng, Tian, Xiaolong, Wang, Yulu, Zhao, Qi, Li, Wei, Prabakaran, Ponraj, Feng, Yang, Cardosa, Jane, Qin, Chengfeng, Zhou, Xiaohui, Dimitrov, Dimiter S., Ying, Tianlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615639/ https://www.ncbi.nlm.nih.gov/pubmed/31242272 http://dx.doi.org/10.1371/journal.ppat.1007836

Ejemplares similares

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
por: Xiao, Xiaodong, et al.
Publicado: (2009)

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens
por: Chen, Weizao, et al.
Publicado: (2012)

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
por: Zhu, Zhongyu, et al.
Publicado: (2013)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
por: Prabakaran, Ponraj, et al.
Publicado: (2007)

Interactions of IgG1 CH2 and CH3 Domains with FcRn
por: Ying, Tianlei, et al.
Publicado: (2014)

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
por: Ying, Tianlei, et al.
Publicado: (2015)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity
por: Wan, Chao, et al.
Publicado: (2013)

Antibody Aggregation: Insights from Sequence and Structure
por: Li, Wei, et al.
Publicado: (2016)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
por: Feng, Yang, et al.
Publicado: (2014)

A model of the ACE2 structure and function as a SARS-CoV receptor
por: Prabakaran, Ponraj, et al.
Publicado: (2004)

Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
por: Prabakaran, Ponraj, et al.
Publicado: (2012)

The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization
por: Chakraborti, Samitabh, et al.
Publicado: (2005)

454 antibody sequencing - error characterization and correction
por: Prabakaran, Ponraj, et al.
Publicado: (2011)

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
por: Prabakaran, Ponraj, et al.
Publicado: (2006)

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
por: Chen, Weizao, et al.
Publicado: (2010)

Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017)

Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy
por: Zhu, Xiaoyi, et al.
Publicado: (2021)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

Structure of an isolated unglycosylated antibody C(H)2 domain
por: Prabakaran, Ponraj, et al.
Publicado: (2008)

Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
por: Agrawal, Anurodh Shankar, et al.
Publicado: (2016)

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin
por: Yu, Fei, et al.
Publicado: (2017)

Human Monoclonal Antibodies Against HIV and Emerging Viruses
por: Dimitrov, Dimiter S.
Publicado: (2008)

Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus
por: Ying, Tianlei, et al.
Publicado: (2016)

Precision immunomedicine
por: Ying, Tianlei, et al.
Publicado: (2017)

A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity
por: Feng, Yang, et al.
Publicado: (2011)

Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn
por: Gong, Rui, et al.
Publicado: (2012)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

In-Depth Analysis of Human Neonatal and Adult IgM Antibody Repertoires
por: Hong, Binbin, et al.
Publicado: (2018)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2021)

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
por: Zakir, Tasnim Saifudin, et al.
Publicado: (2022)

Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head
por: Wang, Yulu, et al.
Publicado: (2020)

A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia
por: Schneider, Dina, et al.
Publicado: (2018)

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
por: McGuire, Andrew T., et al.
Publicado: (2013)

Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model
por: Xiao, Xiaodong, et al.
Publicado: (2010)

Landscape of Non-canonical Cysteines in Human V(H) Repertoire Revealed by Immunogenetic Analysis
por: Prabakaran, Ponraj, et al.
Publicado: (2020)

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tb9g6td66a92em2las8f3litrf